Transition Therapeutics Inc Company Profile

05:19 EDT 23rd March 2019 | BioPortfolio

Transition Therapeutics Inc. is a fully integrated biopharmaceutical company with a proprietary state-of-the art drug discovery engine and extensive drug development program exploring novel therapeutics in multiple disease indications. The focus of the corporate business is to discover and advance lead molecules to the most valuable and competitive targets in the industry using our state-of-the-art drug discovery engine, to accelerate the development of multiple products for large disease indications and to generate shareholder value through partnership with major pharmaceutical companies.


MaRS Centre, Heritage Building 101 College Street, Suite 220
M5G 1L7


Phone: 416-260-7770
Fax: 416-260-2886

News Articles [1029 Associated News Articles listed on BioPortfolio]

Transition Therapeutics licenses drug candidate from Eli Lilly

Transition Therapeutics announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") fro...

[Correspondence] From silos to sustainability: transition through a UHC lens

The transition to higher-income status is a positive step forward for countries, but this transition brings with it the prospect of declining external assistance, both in general and in particular for...

Abeona Therapeutics Announces CEO Transition

NEW YORK and CLEVELAND, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene thera...

Unum Therapeutics Announces Transition of Chief Financial Officer

CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of novel cellular immunotherapies, t...

Why certain compounds have the potential to convert light into electrical energy

Transition-metal complexes - that is a cumbersome word for a class of molecules with important properties: An element from the group of transition metals sits in the centre. The outer electrons of the...

Autolus Therapeutics plc (AUTL) CEO Christian Itin on Transition Period from October 1 to December 31, 2018 - Earnings Call Transcript

Axovant Launches Arvelle Therapeutics to Commercialize Epilepsy Drug

Axovant Sciences, one of Vivek Ramaswamy’s biotech companies under the Roivant Sciences’ umbrella, is forming a company called Arvelle Therapeutics. Arvelle is a strategic transition of Axovant’...

Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company

Transition of small molecule expertise to Arvelle completes transformation of Axovant into a company focused exclusively on gene therapiesAxovant will receive a preferred equity stake in Arvelle, whi...

Drugs and Medications [66 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]


Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [1268 Associated PubMed Articles listed on BioPortfolio]

Potential immmunohistochemical markers to characterize epithelial-mesenchymal transition in pleomorphic adenoma.

The histogenesis process of pleomorphic adenoma (PA) of salivary gland continues to remain a controversial subject. In this neoplasm, transition occurs from an epithelial or myoepithelial cell to a st...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

Transition as a topic in psychiatry training throughout Europe: trainees' perspectives.

The majority of adolescents with mental health problems do not experience continuity of care when they reach the transition boundary of their child and adolescent mental health service. One of the obs...

Insulator-metal transition induced by electric voltage in a Ruthenate Mott insulator.

We report the observation of electric-voltage induced insulator-metal phase transition in a ruthenate Mott insulator Ca3(Ru0.9Ti0.1)2O7. We show that the electric field effect dominates and leads to a...

Clinical Trials [605 Associated Clinical Trials listed on BioPortfolio]

Transition of Diabetes Care From Pediatric to Adult Healthcare Providers.

A dedicated pre-transition class, as proposed in this study, could help facilitate a smooth transition between pediatric and adult diabetes care. The innovation in this study is that these...

Automated Youth-To-Adult Transition Planning Using Health Information ...

This study seeks to automate the process of youth to adult transition using an existing computerized decision support system in primary care. Subjects will complete the TRAQ readiness ques...

: TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)

This study is a single center study of clinical and laboratory outcomes in patients ≥ 12 who transition from use of Orkambi to tez/iva. Clinical and laboratory measurements will be measu...

Evaluation of Web-based Transition Education to Enhance Transition Readiness

The study looks to learn more about the helpfulness of web-based transition education and its effect on transition readiness and health service utilization in the adolescent and young adul...

Tailored Transition for IBD Adolescents

Background: Smooth transition of adolescent patients diagnosed with inflammatory bowel diseases (IBD) to adult care is necessary in order to secure continues clinical management and to pre...

Companies [1422 Associated Companies listed on BioPortfolio]

Transition Therapeutics Inc

Transition Therapeutics Inc. is a fully integrated biopharmaceutical company with a proprietary state-of-the art drug discovery engine and extensive drug development program exploring novel therapeuti...

Elan Corporation, plc and Transition Therapeutics, Inc.

Transition Therapeutics Inc.

Transition Therapeutics Inc. is a fully integrated biopharmaceutical company with a proprietary state-of-the art drug discovery engine and extensive drug development program exploring novel therapeuti...

iGetBetter, Inc.

Established in 2013, iGetBetter, Inc. develops, markets and services a Web-based care transition solution designed to help healthcare organizations reduce readmissions by remotely...

BCG (Europe) Ltd

The first few years of the new Millennium have been particularly difficult for Biotechnology companies, particularly those in the Biopharmaceutical sector.Apart from the well recognised difficulties i...

More Information about "Transition Therapeutics Inc" on BioPortfolio

We have published hundreds of Transition Therapeutics Inc news stories on BioPortfolio along with dozens of Transition Therapeutics Inc Clinical Trials and PubMed Articles about Transition Therapeutics Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Transition Therapeutics Inc Companies in our database. You can also find out about relevant Transition Therapeutics Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record